Lifespan Cancer Institute among 6 groups studying digital symptom reporting benefit

PROVIDENCE – The Lifespan Cancer Institute is among six cancer programs nationally participating in the $9 million SIMPRO study investigating whether electronic reporting of symptoms decreases hospitalizations after surgery or chemotherapy. The SIMPRO, or Symptom Management Implementation of Patient Reported Outcomes in Oncology study, is funded by the National Cancer Institute in association with the…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -